martes, 13 de septiembre de 2022

FDAnews Webinar: Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis

FDAnews Webinar: Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis

No hay comentarios: